Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients
MSN News Science Alert
11 February 2021
https://www.msn.com/en-us/news/technology/scientists-think-theyve-figured-out-whats-triggering-brain-fog-in-covid-19-patients/ar-BB1dBTTF?li=BBnbfcL
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients
Cancer Cell
16 January 2021
https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00051-9
The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice
Gynecol Oncol
30 April 2011
https://pubmed.ncbi.nlm.nih.gov/21531450/
Low-dose naltrexone: tricking the body to heal itself
Exp Biol Med (Maywood)
September 2011
https://www.sciencedaily.com/releases/2011/09/110902133047.htm
Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment
Invest New Drugs
August 2013
https://pubmed.ncbi.nlm.nih.gov/23275062/
Metabolic treatment of cancer: intermediate results of a prospective case series
Anticancer Res
February 2014
https://pubmed.ncbi.nlm.nih.gov/24511042/
Background: The combination of hydroxycitrate and lipoic acid has been demonstrated by several laboratories to be effective in reducing murine cancer growth.
Long-term remission of adenoid cystic tongue carcinoma with low dose naltrexone and vitamin D3--a case report
Oral Health Dent Manag
September 2014
http://oralhealth.ro/volumes/2014/volume-3/Paper662.pdf
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases
Integr Cancer Ther
December 2009
https://pubmed.ncbi.nlm.nih.gov/20042414/
Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone
Cancer Lett
29 March 1996
https://pubmed.ncbi.nlm.nih.gov/8620464/